[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334177-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334177-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","epidermal-growth-factor-receptor-egfr-and-smad4-negatively-correlated-in-the-progression-of-gallbladder-cancer-in-eastern-indian-patients","Epidermal Growth Factor Receptor (EGFR) and SMAD4 Negatively Correlated in the Progression of Gallbladder Cancer in Eastern Indian Patients","","Study investigates molecular mechanisms underlying gallbladder adenocarcinoma progression in Eastern Indian patients by examining oncogenic EGFR and ERBB2/Her2-neu alterations and tumor suppressor SMAD4 dysregulation. Mutational and genotypic evaluation targets KRAS codon 12, ERBB2/Her2-neu amplification, and SNPs (ERBB2/Her2-neu, CCND1), alongside gene expression profiling of six dysregulated genes. Bacterial infection markers for S. Typhi and H. pylori and TGF-beta expression changes are assessed to link inflammation and cancer progression. Results show significant EGFR and ERBB2 overexpression with SMAD4 downregulation, with EGFR–SMAD4 negative correlation validated by IHC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/epidermal-growth-factor-receptor-egfr-and-smad4-negatively-correlated-in-the-progression-of-gallbladder-cancer-in-eastern-indian-patients/334177/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/epidermal-growth-factor-receptor-egfr-and-smad4-negatively-correlated-in-the-progression-of-gallbladder-cancer-in-eastern-indian-patients/334177.png","ImageObject",300,407,{"name":42,"@type":43},"Seraphina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main molecular focus of the study in Eastern Indian gallbladder cancer patients?","Question",{"text":63,"@type":64},"The study focuses on oncogenic EGFR and ERBB2/Her2-neu and the tumor suppressor SMAD4, evaluating their mutational status, amplification, and expression patterns during gallbladder cancer progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which gene alterations and markers are assessed in the study?",{"text":68,"@type":64},"The study assesses KRAS codon 12 mutations, ERBB2/Her2-neu amplification and SNPs, CCND1 SNPs, and expression of CCND1, MYC, CDKN2A, ERBB2/Her2-neu, EGFR, and SMAD4, alongside TGF-beta status.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationship between EGFR and SMAD4 is reported, and how is it validated?",{"text":72,"@type":64},"EGFR and SMAD4 expression are found to be negatively correlated in gallbladder cancer tissue samples, with statistical significance and validation using the IHC technique.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334177,1790013016,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Choudhury etal. BMCGastroenterology (2024) 24:446  \n[https://doi.org/10.1186/s12876-024-03485-4](https://doi.org/10.1186/s12876-024-03485-4)  \nBMC Gastroenterology  \n RESEARCH Open Access  \nEpidermal Growth Factor Receptor (EGFR) and SMAD4 negatively correlated in the progression of gallbladder cancer in Eastern Indian patients  \nSounetra Choudhury1, Sandip Ghosh4, Prosenjeet Chakraborty1, Sayari Pal 1, Koustuv Ghosh1, Subhankar Saha3, Jitesh Midha2, Vinu Sankar3, Abhisek Mohata3, Bitan Kumar Chattopadhyay2, Shibajyoti Ghosh3, Soumen Das2, Biswarup Basu4 and Nilabja Sikdar1,5*  \nAbstract  \nBackground and introduction Two and half percent of the Indian population suffer from gallbladder cancer (GBC) . The primary factors that lead GBC are associated with mutation of several protooncogenes such as EGFR, ERBB2, Myc, and CCND1 along with dysregulation of several tumor suppressor genes such as SMAD4 and CDKN2A. Bacterial infection caused by S. typhi and H.pylori are also hypothesized to be potential factors driving GBC.  \nAims This study aims to investigate the molecular mechanisms driving the progression of gallbladder adenocarcinoma in Eastern Indian patients. We specifically focussed on analyzing the mutational status of the KRAS gene, examining the amplification ofthe ERBB2/Her2-neu gene, and evaluating the expression patterns of six dysregulated genes (CCND1, MYC, EGFR, ERBB2/Her2-neu, CDKN2A, SMAD4) . Additionally, we assessed the expression status ofTGFbeta, the association between bacterial infections (S. Typhi and H. pylori) and GBC, and the impact of single nucleotide polymorphisms in ERBB2/Her2-neu and CCND1 genes within this population.  \nMethods Sixty-seven samples from GBC-diagnosed patients, 26 other unrelated GBC samples for validation cohort, and 68 gallstone tissue samples were collected for this study. Genomic DNA from normal as well as tumor tissues were isolated, exon 2 and exon 3 ofKRAS gene were amplified along, DNA sequenced and analyzed. KRAS codon 12 mutation was detected by allele specific PCR (ASPCR) method. Amplification of UreCA (coding for urease subunit α), VacA (coding for Vacuolating cytotoxin A) and CagA genes (coding for cytotoxin-associated gene A) in H.pylori were amplified using PCR. Similarly, FlicC (coding for flagellin gene C) in S. typhi was amplified using PCR. The ERBB2/Her2-neu SNPI655V, and CCND1 SNP A870G were analyzed using PCR followed by RFLP. Expression studies of CCND1, Myc, CDKN2A, ERBB2/Her2-neu, EGFR, and SMAD4 genes were measured in GBC tumor tissues by sybr green quantitative RT PCR. Results The oncogenes (EGFR and ERBB2/Her2-neu) were statistically significantly overexpressed and the tumor suppressor gene (SMAD4) downregulated in our GBC tumor patient samples. The EGFR and SMAD4 genes were negatively correlated (r = -0.01) in GBC patients and the data is statistically significant and validated through IHC technique. A significant downregulation of TGF-beta had also been observed. Lower frequency (i. e. 11. 5%) of KRAS mutation in GBC tumor was observed.  \n*Correspondence: Nilabja Sikdar  \n[snilabja@isical.ac.in](snilabja@isical.ac.in); [snilabja@gmail.com](snilabja@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is n","cbCaisipxqs86dcx","https://ap.wps.com/l/cbCaisipxqs86dcx","pdf",8968923,21,"English","# Abstract\n## Background and introduction\n## Aims\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Disease overview and epidemiology\n## Risk factors","[{\"question\":\"What is the main molecular focus of the study in Eastern Indian gallbladder cancer patients?\",\"answer\":\"The study focuses on oncogenic EGFR and ERBB2/Her2-neu and the tumor suppressor SMAD4, evaluating their mutational status, amplification, and expression patterns during gallbladder cancer progression.\"},{\"question\":\"Which gene alterations and markers are assessed in the study?\",\"answer\":\"The study assesses KRAS codon 12 mutations, ERBB2/Her2-neu amplification and SNPs, CCND1 SNPs, and expression of CCND1, MYC, CDKN2A, ERBB2/Her2-neu, EGFR, and SMAD4, alongside TGF-beta status.\"},{\"question\":\"What relationship between EGFR and SMAD4 is reported, and how is it validated?\",\"answer\":\"EGFR and SMAD4 expression are found to be negatively correlated in gallbladder cancer tissue samples, with statistical significance and validation using the IHC technique.\"}]","Epidermal Growth Factor Receptor (EGFR) and SMAD4 Negatively Correlated in the Progression of Gallbladder Cancer in Eastern Indian Patients | PDF",1790005657,53]